Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies

被引：26

作者：

Schweitzer, N. ^{[1
]}

Vogel, A. ^{[1
]}

机构：

[1] Dept Gastroenterol Hepatol & Endcrinol, D-30625 Hannover, Germany

来源：

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2015年 / 29卷 / 02期

关键词：

Cholangiocarcinoma; Biliary tract cancer; Chemotherapy; Gemcitabine; Targeted therapy; ADVANCED BILIARY-TRACT; PHASE-II TRIAL; GALL-BLADDER CANCER; GALLBLADDER CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; 1ST-LINE TREATMENT; 2ND-LINE TREATMENT; PLUS GEMCITABINE; BILE-DUCT; TRANSARTERIAL CHEMOEMBOLIZATION;

D O I：

10.1016/j.bpg.2015.01.002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Cholangiocarcinomas (CCA) are rare tumors of the liver with poor prognosis. The standard of care in patients with unresectable tumors or metastatic disease is combination chemotherapy (CT) with gemcitabine and cisplatin. Targeted therapies inhibiting EGFR, VEGF, MEK and others are broadly tested in CCA but to date, the existing data from randomized and nonrandomized trials do not justify the application of small molecules outside of clinical trials. In clinical practice, many patients receive second-line CT after failure of gemcitabine/cisplatin, although there is so far no evidence to support second-line CT. This review summarizes current chemotherapy protocols and ongoing studies, including conventional chemotherapy and targeted therapies. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：345 / 353

页数：9

共 50 条

[31] Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma [J].

Cho, Su Min ;

Esmail, Abdullah ;

Raza, Ali ;

Dacha, Sunil ;

Abdelrahim, Maen .

CANCERS, 2022, 14 (11)

[32] Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy [J].

Gim, Gahyun ;

Badri, Nabeel .

HEPATOMA RESEARCH, 2023, 9

[33] Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study [J].

Zheng, Zhikai ;

Wang, Jiongliang ;

Wu, Tianqing ;

He, Minrui ;

Pan, Yangxun ;

Wang, Juncheng ;

Chen, Jinbin ;

Hu, Dandan ;

Xu, Li ;

Zhang, Yaojun ;

Chen, Minshan ;

Zhou, Zhongguo .

INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) :1552-1557

[34] Resistance to Chemotherapy and Molecularly Targeted Therapies: Rationale for Combination Therapy in Malignant Melanoma [J].

Wu, S. ;

Singh, R. K. .

CURRENT MOLECULAR MEDICINE, 2011, 11 (07) :553-563

[35] Advances in Chemotherapy and Targeted Systemic Therapies for Urothelial Cancer [J].

Crabb, Simon J. ;

Wheater, Matthew .

CURRENT DRUG THERAPY, 2010, 5 (01) :17-28

[36] Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures [J].

Rizzo, Alessandro ;

Tavolari, Simona ;

Ricci, Angela Dalia ;

Frega, Giorgio ;

Palloni, Andrea ;

Relli, Valeria ;

Salati, Massimiliano ;

Fenocchio, Elisabetta ;

Massa, Annamaria ;

Aglietta, Massimo ;

Brandi, Giovanni .

CANCERS, 2020, 12 (11) :1-15

[37] Systemic therapy of cholangiocarcinoma [J].

Lutz, M. P. ;

Matzdorff, A. .

ONKOLOGE, 2010, 16 (09) :898-900

[38] Chemotherapy and targeted therapies for unresectable malignant mesothelioma [J].

Kelly, Ronan Joseph ;

Sharon, Elad ;

Hassan, Raffit .

LUNG CANCER, 2011, 73 (03) :256-263

[39] Systemic and Targeted Therapies in Adenoid Cystic Carcinoma [J].

Kacew, Alec J. J. ;

Hanna, Glenn J. J. .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (01) :45-60

[40] Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma [J].

Gonzalez-Carmona, Maria Angeles ;

Bolch, Maximilian ;

Jansen, Christian ;

Vogt, Annabelle ;

Sampels, Matthias ;

Mohr, Raphael U. ;

van Beekum, Katrin ;

Mahn, Robert ;

Praktiknjo, Michael ;

Nattermann, Jacob ;

Trebicka, Jonel ;

Branchi, Vittorio ;

Matthaei, Hanno ;

Manekeller, Steffen ;

Kalff, Joerg C. ;

Strassburg, Christian P. ;

Weismueller, Tobias J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (04) :437-447

← 1 2 3 4 5 →